Lupin - Quaterly Results

27 Oct 2021 Evaluate
The sales for the September 2021 quarter moved down to Rs. 28701.70 millions as compared to Rs. 30426.00 millions during the year-ago period.The Net Loss for the quarter ended September 2021 is Rs. -13291.20 millions as compared to Net Profit of Rs. 3604.30 millions of corresponding quarter ended September 2020Operating profit Margin for the quarter ended September 2021 slipped to -13242.70% as compared to 6230.70% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 28701.70 30426.00 -5.67 61842.90 57376.80 7.78 110559.30 110256.60 0.27
Other Income 746.80 252.90 195.29 1263.60 593.00 113.09 1290.90 4751.90 -72.83
PBIDT -13242.70 6230.70 -312.54 -3347.20 12523.80 -126.73 21731.50 23828.00 -8.80
Interest 182.60 91.30 100.00 330.80 178.10 85.74 406.20 525.90 -22.76
PBDT -13425.30 6139.40 -318.67 -3678.00 12345.70 -129.79 21325.30 15710.00 35.74
Depreciation 1299.00 1256.00 3.42 2552.60 2507.40 1.80 5028.30 5187.50 -3.07
PBT -14724.30 4883.40 -401.52 -6230.60 9838.30 -163.33 16297.00 10522.50 54.88
TAX -1433.10 1279.10 -212.04 601.90 2598.20 -76.83 3710.80 3247.00 14.28
Deferred Tax 1760.30 -20.30 -8771.43 1729.70 -73.80 -2443.77 82.30 -373.50 -122.03
PAT -13291.20 3604.30 -468.76 -6832.50 7240.10 -194.37 12586.20 7275.50 72.99
Equity 908.10 906.50 0.18 908.10 906.50 0.18 907.40 906.00 0.15
PBIDTM(%) -46.14 20.48 -325.31 -5.41 21.83 -124.80 19.66 21.61 -9.05

Lupin Share Price

2167.35 -10.85 (-0.50%)
20-Jan-2026 12:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.80
Dr. Reddys Lab 1184.75
Cipla 1378.90
Zydus Lifesciences 877.00
Lupin 2167.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×